M. Debruin

发表

A pilot trial of recombinant interleukin-12 in patients with chronic hepatitis C who previously failed treatment with interferon-α

C. O'brien, B. S. Henzel, D. Moonka, 2001, American Journal of Gastroenterology.

A pilot trial of recombinant Interleukin-12 in patients with chronic hepatitis C who previously failed treatment with interferon-α

C. O'brien, B. S. Henzel, D. Moonka, 2001 .

Leading article Development of daptomycin for Gram-positive infections

F. Tally, M. Debruin, M. DeBruin, 2000 .

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.

A. Buchman, S. Hanauer, B. Sands, 1999, Gastroenterology.

Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group.

D. Greenspan, V. Pons, M. Debruin, 1993, Journal of acquired immune deficiency syndromes.

Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects

R. Arbeit, B. Dvorchik, D. Brazier, 2003, Antimicrobial Agents and Chemotherapy.

Development of daptomycin for gram-positive infections.

F. Tally, M. Debruin, M. DeBruin, 2000, Journal of Antimicrobial Chemotherapy.

Phase 1 Trial of a Single Dose of Recombinant Human Interleukin—12 in Human Immunodeficiency Virus—Infected Patients with 100–500 CD4 Cells/µL

M. Jacobson, E. Connick, D. Hardy, 2000 .

A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy

R. Carithers, J. McHutchison, M. Tong, 2003, Hepatology.

Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.

M. Jacobson, E. Connick, D. Hardy, 2000, The Journal of infectious diseases.